ECO ANIMAL HEALTH GROUP PLC LONDON--(BUSINESS WIRE)--
ECO Animal Health Group plc
(AIM: EAH)
ECO Animal Health and Agrinnovation (Yissum) L.P. sign swine antimicrobial novel formulation development and licencing deal
ECO Animal Health Ltd (ECO), a wholly owned subsidiary of ECO Animal Health Group plc, is pleased to announce that it has entered a development and licensing deal with Agrinnovation and Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., State of Israel.
This deal, based on a number of milestone payments, allows ECO to licence patented research related innovations leading to the development of a unique long acting injectable florfenicol product to treat swine bacterial respiratory disease with a single dose. Florfenicol is an antimicrobial used only in veterinary medicine and the product will complement both the spectrum of activity and the oral route of administration of Aivlosin ®, ECO's patented molecule for the treatment of economically important diseases in pigs and poultry.
Peter Lawrence, Non-executive Chairman of ECO Animal Health Group plc said, 'Recent market research has indicated that treatment for respiratory disease accounts for over 40% of antimicrobial treatments in finishing pigs. We are delighted to have entered this collaboration with Agrinnovation '.
Dr. Ido Schechter, Agrinnovation CEO said, 'We are excited to enter this collaboration with ECO, which underscores the promise of agricultural research at Hebrew University and supports our vision of sustainable agriculture around the world through collaborations between industry and academic organizations.'
The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ('MAR').Upon the publication of this announcement via a Regulatory Information Service ('RIS'), this inside information is now considered to be in the public domain.
Contacts:
ECO Animal Health Group plc
| Peter Lawrence | 020 8336 6190 | ||
| Marc Loomes | 020 8447 6906 | ||
| Spiro Financial | |||
| Anthony Spiro | 020 8336 6196 | ||
| N+1 Singer (Nominated Adviser) | 020 7496 3000 | ||
| Mark Taylor, Brough Ransom | |||
| Peel Hunt LLP (Joint Broker) | |||
| James Steel, Dr Christopher Golden | 020 7418 8900 | ||
-----------------------------------------------------
About ECO Animal Health Ltd
ECO Animal Health based in London U.K. is a leader in the development, registration and marketing of pharmaceutical products for global animal health markets. Its products for these growth markets promote well-being in animals and include the novel antimicrobial, Aivlosin®, as well as a range of generic therapeutic products.
About Agrinnovation (Yissum) L.P.
Agrinnovation is a limited partnership affiliated with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., State of Israel, entitled to invest in, develop and commercialise projects in the field of veterinary medicine based on inventions generated by scientists of the University.
View source version on businesswire.com:https://www.businesswire.com/news/home/20181202005043/en/
Eco Animal Health Group Plc
Source: Eco Animal Health Group Plc
Attachments
- Original document
- Permalink
Disclaimer
Eco Animal Health Group plc published this content on 03 December 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 03 December 2018 07:06:08 UTC
